← Evidence map

ArticleResearch and practice in thrombosis and haemostasis2026

Corrigendum to 'Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trial': [RPTH, 103360, January 2026, Volume 10, Issue 1].

Robert Klamroth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Corrigendum to 'Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trial': [RPTH, 103360, January 2026, Volume 10, Issue 1]. | Socratic